For mechanisms, Prkci positively activates the Akt/mTOR signaling pathway in osteosarcoma; Prkci regulates the activity of the oncogenic transcription factor YAP1 by modulating binding of YAP1 to AMOT130 in ovarian cancer7,10–12. This evidence concerns the gene PRKCI and osteosarcoma.